PKC links Gq-coupled receptors to DAT-mediated dopamine release

Journal of Neurochemistry

Volumn 114, Issue 2, 2010, Pages 587-596

  Opazo, Felipe ^a,b,d   Schulz, Jörg B ^c   Falkenburger, Björn H ^a,b  

^a Center for Neurological Medicine   (Germany)

^b Deutsche Forschungsgemeinschaft   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d EUROPEAN NEUROSCIENCE INSTITUTE   (Germany)

Author keywords

amperometry; basal ganglia physiology; dopamine transport; metabotropic receptors; neurotransmitter release; protein kinase C signaling

Indexed keywords

DOPAMINE; METABOTROPIC RECEPTOR; MUSCARINIC RECEPTOR; NORADRENALIN TRANSPORTER; PROTEIN KINASE C; CARBACHOL; DOPAMINE TRANSPORTER; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; SLC6A3 PROTEIN, HUMAN; SLC6A3 PROTEIN, MOUSE;

AMPEROMETRY; ARTICLE; BASAL GANGLION; BRAIN REGION; CONTROLLED STUDY; DOPAMINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOTOR PERFORMANCE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; ANIMAL; ENZYME ACTIVATION; GENETICS; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; WISTAR RAT;

RATTUS;

ANIMALS; BIOLOGICAL TRANSPORT; CARBACHOL; CELL LINE, TUMOR; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENZYME ACTIVATION; GLUTAMIC ACID; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, MUSCARINIC; SUBSTANTIA NIGRA;

EID: 77953856061     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06788.x     Document Type: Article

References (57)

1. Andersson D. R., Nissbrandt H. Bergquist F. (2006) Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission. Eur. J. Neurosci. 24, 617 624.
2. + signaling by the membrane potential. J. Neurosci. 26, 9983 9995.
3. Björklund A. Lindvall O. (1975) Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res. 83, 531 537.
4. Boudanova E., Navaroli D. M. Melikian H. E. (2008) Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology 54, 605 612.
5. Carruthers A. M., Challiss R. A., Mistry R., Saunders R., Thomsen C. Nahorski S. R. (1997) Enhanced type 1alpha metabotropic glutamate receptor-stimulated phosphoinositide signaling after pertussis toxin treatment. Mol. Pharmacol. 52, 406 414.
6. Cervinski M. A., Foster J. D. Vaughan R. A. (2005) Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms. J. Biol. Chem. 280, 40442 40449.
7. Cheema T. A., Pettigrew V. A. Fisher S. K. (2007) Receptor regulation of the volume-sensitive efflux of taurine and iodide from human SH-SY5Y neuroblastoma cells: differential requirements for Ca(2+) and protein kinase C. J. Pharmacol. Exp. Ther. 320, 1068 1077.
8. Chen B. T. Rice M. E. (2001) Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. J. Neurosci. 21, 7841 7847.
9. Chen B. T., Moran K. A., Avshalumov M. V. Rice M. E. (2006) Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release. J. Neurochem. 96, 645 655.
10. Cheramy A., Leviel V. Glowinski J. (1981) Dendritic release of dopamine in the substantia nigra. Nature 289, 537 542.
11. Cowell R. M., Kantor L., Hewlett G. H., Frey K. A. Gnegy M. E. (2000) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur. J. Pharmacol. 389, 59 65.
12. Daniels G. M. Amara S. G. (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 35794 35801.
13. Dietz G. P., Stockhausen K. V., Dietz B. et al. (2008) Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra. J. Neurochem. 104, 757 765.
14. Eriksen J., Rasmussen S. G., Rasmussen T. N., Vaegter C. B., Cha J. H., Zou M. F., Newman A. H. Gether U. (2009) Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs. J. Neurosci. 29, 6794 6808.
15. Fagerstrom S., Pahlman S. Nanberg E. (1998) Protein kinase C-dependent tyrosine phosphorylation of p130cas in differentiating neuroblastoma cells. J. Biol. Chem. 273, 2336 2343.
16. Falkenburger B. H., Barstow K. L. Mintz I. M. (2001) Dendrodendritic inhibition through reversal of dopamine transport. Science 293, 2465 2470.
17. Fog J. U., Khoshbouei H., Holy M. et al. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417 429.
18. Fortin G. D., Desrosiers C. C., Yamaguchi N. Trudeau L. E. (2006) Basal somatodendritic dopamine release requires snare proteins. J. Neurochem. 96, 1740 1749.
19. Foster J. D., Pananusorn B. Vaughan R. A. (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277, 25178 25186.
20. Geffen L. B., Jessell T. M., Cuello A. C. Iversen L. L. (1976) Release of dopamine from dendrites in rat substantia nigra. Nature 260, 258 260.
21. Granas C., Ferrer J., Loland C. J., Javitch J. A. Gether U. (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278, 4990 5000.
22. Hille B., Billiard J., Babcock D. F., Nguyen T. Koh D. S. (1999) Stimulation of exocytosis without a calcium signal. J. Physiol. 520 Pt 1, 23 31.
23. Hoffman A. F. Gerhardt G. A. (1999) Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. J. Pharmacol. Exp. Ther. 289, 455 463.
24. Holton K. L., Loder M. K. Melikian H. E. (2005) Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat. Neurosci. 8, 881 888.
25. Hoshi N., Langeberg L. K., Gould C. M., Newton A. C. Scott J. D. (2010) Interaction with AKAP79 modifies the cellular pharmacology of PKC. Mol. Cell 37, 541 550.
26. Ibanez-Sandoval O., Hernandez A., Floran B., Galarraga E., Tapia D., Valdiosera R., Erlij D., Aceves J. Bargas J. (2006) Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors. J. Neurophysiol. 95, 1800 1811.
27. Jaffe E. H., Marty A., Schulte A. Chow R. H. (1998) Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices. J. Neurosci. 18, 3548 3553.
28. Janowsky A., Neve K. A. Eshleman A. J. (1998) Uptake and release of neurotransmitters, in Current Protocols in Neuroscience (Crawley J., Gerfen C., McKay R., Rogawski M., Sibley D. Skolnick P., eds), pp. 7.9.1 7.9.22. John Wiley & Sons, Inc.
29. Jansson C. C., Kukkonen J. Akerman K. E. (1991) Muscarinic receptor-linked elevation of cAMP in SH-SY5Y neuroblastoma cells is mediated by Ca2+ and protein kinase C. Biochim. Biophys. Acta 1095, 255 260.
30. Johnson L. A., Guptaroy B., Lund D., Shamban S. Gnegy M. E. (2005) Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta. J. Biol. Chem. 280, 10914 10919.
31. Kantor L. Gnegy M. E. (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J. Pharmacol. Exp. Ther. 284, 592 598.
32. Katz J. L., Kopajtic T. A., Agoston G. E. Newman A. H. (2004) Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J. Pharmacol. Exp. Ther. 309, 650 660.
33. Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M. E., Galli A. Javitch J. A. (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2, E78.
34. Kim J. H., Choi S., Jung J. E., Roh E. J. Kim H. J. (2006) Capacitative Ca2+ entry is involved in regulating soluble amyloid precursor protein (sAPPalpha) release mediated by muscarinic acetylcholine receptor activation in neuroblastoma SH-SY5Y cells. J. Neurochem. 97, 245 254.
35. Kosinski C. M., Standaert D. G., Testa C. M., Penney J. B. Jr. Young A. B. (1998) Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat. Neuroscience 86, 783 798.
36. Lester H. A., Mager S., Quick M. W. Corey J. L. (1994) Permeation properties of neurotransmitter transporters. Annu. Rev. Pharmacol. Toxicol. 34, 219 249.
37. Levi G. Raiteri M. (1993) Carrier-mediated release of neurotransmitters. Trends Neurosci. 16, 415 419.
38. Levites Y., Amit T., Youdim M. B. Mandel S. (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem. 277, 30574 30580.
39. Litschig S., Gasparini F., Rueegg D., Stoehr N., Flor P. J., Vranesic I., Prezeau L., Pin J. P., Thomsen C. Kuhn R. (1999) CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. Mol. Pharmacol. 55, 453 461.
40. Lu W. Y., Xiong Z. G., Lei S., Orser B. A., Dudek E., Browning M. D. MacDonald J. F. (1999) G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat. Neurosci. 2, 331 338.
41. Martin L. P. Waszczak B. L. (1994) D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway. J. Neurosci. 14, 4494 4506.
42. McElvain J. S. Schenk J. O. (1992) A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem. Pharmacol. 43, 2189 2199.
43. Mintz I., Hammond C., Guibert B. Leviel V. (1986) Stimulation of the subthalamic nucleus enhances the release of dopamine in the rat substantia nigra. Brain Research 376, 406 408.
44. Miura M., Watanabe M., Offermanns S., Simon M. I. Kano M. (2002) Group I metabotropic glutamate receptor signaling via Galpha q/Galpha 11 secures the induction of long-term potentiation in the hippocampal area CA1. J. Neurosci. 22, 8379 8390.
45. Nirenberg M. J., Vaughan R. A., Uhl G. R., Kuhar M. J. Pickel V. M. (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16, 436 447.
46. Patel J. C., Witkovsky P., Avshalumov M. V. Rice M. E. (2009) Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release. J. Neurosci. 29, 6568 6579.
47. Rice M. E., Cragg S. J. Greenfield S. A. (1997) Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. J. Neurophysiol. 77, 853 862.
48. Ruffieux A. Schultz W. (1980) Dopaminergic activation of reticulata neurones in the substantia nigra. Nature 285, 240 241.
49. Saunders C., Ferrer J. V., Shi L., Chen J., Merrill G., Lamb M. E., Leeb-Lundberg L. M., Carvelli L., Javitch J. A. Galli A. (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl Acad. Sci. USA 97, 6850 6855.
50. Schwartz E. A. (1987) Depolarization without calcium can release gamma-aminobutyric acid from a retinal neuron. Science 238, 350 355.
51. Solano D. C., Sironi M., Bonfini C., Solerte S. B., Govoni S. Racchi M. (2000) Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J. 14, 1015 1022.
52. Stea A., Soong T. W. Snutch T. P. (1995) Determinants of PKC-dependent modulation of a family of neuronal calcium channels. Neuron 15, 929 940.
53. Sulzer D., Sonders M. S., Poulsen N. W. Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406 433.
54. Testa C. M., Standaert D. G., Young A. B., Penney J. B. Jr. (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14, 3005 3018.
55. Thompson L. J. Fields A. P. (1996) betaII protein kinase C is required for the G2/M phase transition of cell cycle. J. Biol. Chem. 271, 15045 15053.
56. Windels F. Kiyatkin E. A. (2006) Dopamine action in the substantia nigra pars reticulata: iontophoretic studies in awake, unrestrained rats. Eur. J. Neurosci. 24, 1385 1394.
57. Wu Y., Wang W., Diez-Sampedro A. Richerson G. B. (2007) Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1. Neuron 56, 851 865.